Ega - European Generic and Biosimilar Medicines Association

the ega is the official representative body of the european generic and biosimilar pharmaceutical industry, which is at the forefront of providing high-quality affordable medicines to millions of european patients and stimulating competitiveness and innovation in the pharmaceutical sector. formed in 1993, the ega represents generic pharmaceutical companies and their subsidiaries from throughout europe, either directly or through national associations. companies represented within the ega provide over 160,000 jobs in europe. cost-effective generic medicines save eu patients and healthcare systems over €40 billion each year, thus helping to ensure patient access to essential medicines and providing urgently needed budget headroom for the purchase of new and innovative treatments. the ega plays an important consultative part in european healthcare policy-making and provides key educational role for its members. the ega and its members work with european national governments and the eu